Express Scripts Combination With Cigna's PBM Could Reverse Deficit From Losing Anthem
Merger could restore number of covered lives PBM will lose once its contract with Anthem expires, but there is also risk of alienating current health plan clients who don't want to contract with a competitor.
You may also be interested in...
Biopharma financing started the year solidly with $16.6 billion in total deal value, a 14% increase over the previous quarter. Q1 2018 biopharma merger and acquisition deal value, led by Cigna's $67 billion buy of Express Scripts, topped even the previous all-time-high set in Q4 2107, while alliances totaled $30.7 billion and featured big oncology and neurology partnerships.
The health insurer Cigna is poised to acquire the largest independent PBM in the US. With other consolidation throughout the sector, this signals sweeping changes to the way drug distribution is managed.
Big, revolutionary, vertical deals to change structure of health industry are dramatic but tough to pull off. Will CVS PBM customers worry about funding a competitor?